{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:48:48Z","timestamp":1784126928880,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP0371"],"award-info":[{"award-number":["PIP0371"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bbalip.2023.159363","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T11:26:03Z","timestamp":1688815563000},"page":"159363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mechanism of preventive effects of exendin-4 and des-fluoro-sitagliptin in a murine model of fructose-induced prediabetes"],"prefix":"10.1016","volume":"1868","author":[{"given":"Mar\u00eda Cecilia","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n Gonzalo","family":"Villagarc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Schinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Laura","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Francini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2023.159363_bb0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41581-020-00367-2","article-title":"Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence","volume":"17","author":"Alicic","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbalip.2023.159363_bb0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/molecules25081987","article-title":"Type 2 diabetes mellitus: a review of multi-target drugs","volume":"25","author":"Artasensi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bbalip.2023.159363_bb0015","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1210\/en.2008-0945","article-title":"The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action","volume":"150","author":"Ayala","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2023.159363_bb0020","series-title":"Red Cell Metabolism. A manual of Biochemical Methods","author":"Beutler","year":"1975"},{"key":"10.1016\/j.bbalip.2023.159363_bb0025","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/endo.137.7.8770921","article-title":"Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor","volume":"137","author":"Bullock","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2023.159363_bb0030","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2337\/db12-0166","article-title":"GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel","volume":"61","author":"Calabria","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2023.159363_bb0035","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/CS20110665","article-title":"Apocynin administration prevents the changes induced by a fructose-rich diet on rat liver metabolism and the antioxidant system","volume":"123","author":"Castro","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbalip.2023.159363_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/medicina58010008","article-title":"Chronological appearance of endocrine and metabolic dysfunctions induced by an unhealthy diet in rats","volume":"58","author":"Castro","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.bbalip.2023.159363_bb0045","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1096\/fj.13-243634","article-title":"Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids","volume":"28","author":"Cicerchi","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2023.159363_bb0050","doi-asserted-by":"crossref","first-page":"25786","DOI":"10.1074\/jbc.M804372200","article-title":"Exendin-(9-39) corrects fasting hypoglycemia in SUR-1\u2212\/\u2212 mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion","volume":"283","author":"De Le\u00f3n","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159363_bb0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1734-1140(12)70740-5","article-title":"Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect","volume":"64","author":"Dhanesha","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbalip.2023.159363_bb0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","article-title":"The cardiovascular biology of glucagon-like peptide-1","volume":"24","author":"Drucker","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2023.159363_bb0065","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2023.159363_bb0070","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1210\/jcem.87.8.8743","article-title":"Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state","volume":"87","author":"Egan","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2023.159363_bb0075","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1210\/en.2002-220405","article-title":"Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats","volume":"143","author":"Farilla","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2023.159363_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/592760","article-title":"Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat)","volume":"2010","author":"Ferreira","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbalip.2023.159363_bb0085","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1139\/Y09-064","article-title":"Regulation of liver glucokinase activity in rats with fructose-induced insulin resistance and impaired glucose\/lipid metabolism","volume":"87","author":"Francini","year":"2009","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbalip.2023.159363_bb0090","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.lfs.2010.05.005","article-title":"Changes induced by a fructose-rich diet on hepatic metabolism and the antioxidant system","volume":"86","author":"Francini","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.bbalip.2023.159363_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.peptides.2015.10.006","article-title":"Control of liver glucokinase activity: a potential new target for incretin hormones?","volume":"74","author":"Francini","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.bbalip.2023.159363_bb0100","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.4081\/ejh.2020.3160","article-title":"\u03b2-Catenin mediates the effect of GLP-1 receptor agonist on ameliorating hepatic steatosis induced by high fructose diet","volume":"64","author":"Gao","year":"2020","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.bbalip.2023.159363_bb0105","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.metabol.2012.03.002","article-title":"GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases","volume":"61","author":"Hendarto","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2023.159363_bb0110","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.26594","article-title":"High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase","volume":"58","author":"Ishimoto","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2023.159363_bb0115","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2337\/db16-1585","article-title":"NADPH oxidase Nox5 accelerates renal injury in diabetic nephropathy","volume":"66","author":"Jha","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2023.159363_bb0120","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2337\/db14-0100","article-title":"GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering","volume":"63","author":"Kahles","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2023.159363_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107723","article-title":"Anti-inflammatory properties of antidiabetic drugs: a \u201cpromised land\u201d in the COVID-19 era?","volume":"34","author":"Katsiki","year":"2020","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.bbalip.2023.159363_bb0130","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/edrv.20.6.0385","article-title":"The glucagon-like peptides","volume":"20","author":"Kieffer","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbalip.2023.159363_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048801","article-title":"Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver","volume":"7","author":"Lanaspa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2023.159363_bb0140","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","article-title":"Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver","volume":"287","author":"Lanaspa","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159363_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047948","article-title":"Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver","volume":"7","author":"Lanaspa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2023.159363_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3094642","article-title":"Anti-inflammatory effects of GLP-1-based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbalip.2023.159363_bb0155","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0026-0495(96)90183-3","article-title":"Long-term administration of a sucrose-rich diet to normal rats: relationship between metabolic and hormonal profiles and morphological changes in the endocrine pancreas","volume":"45","author":"Lombardo","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2023.159363_bb0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1042\/CS20100372","article-title":"Sitagliptin prevents the development of metabolic and hormonal disturbances, increased B-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats","volume":"120","author":"Maiztegui","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbalip.2023.159363_bb0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbalip.2023.159363_bb0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/nu13020351","article-title":"Incretin hormones in obesity and related cardiometabolic disorders: the clinical perspective","volume":"13","author":"Micha\u0142owska","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bbalip.2023.159363_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/JME-11-0127","article-title":"Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states","volume":"48","author":"Moreno","year":"2012","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bbalip.2023.159363_bb0180","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2009.09.027","article-title":"Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes","volume":"623","author":"Mu","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbalip.2023.159363_bb0185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dom.13129","article-title":"Incretin hormones: their role in health and disease","volume":"20","author":"Nauck","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbalip.2023.159363_bb0190","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2023.159363_bb0195","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.52.3.741","article-title":"Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats","volume":"52","author":"Pospisilik","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2023.159363_bb0200","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1152\/ajpendo.00024.2003","article-title":"Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect","volume":"285","author":"Prigeon","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2023.159363_bb0205","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/nu11081878","article-title":"Incretin hormones: the link between glycemic index and cardiometabolic diseases","volume":"11","author":"Salvatore","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.bbalip.2023.159363_bb0210","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/08977194.2015.1125349","article-title":"Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice","volume":"33","author":"Sancar-Bas","year":"2015","journal-title":"Growth Factors"},{"key":"10.1016\/j.bbalip.2023.159363_bb0215","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.2337\/db11-0203","article-title":"Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans","volume":"60","author":"Salehi","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2023.159363_bb0220","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1194\/jlr.D700017-JLR200","article-title":"A simple and rapid method to assay triacylglycerol in cells and tissues","volume":"48","author":"Schwartz","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2023.159363_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107503","article-title":"Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions","volume":"209","author":"Shao","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbalip.2023.159363_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025269","article-title":"GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy","volume":"6","author":"Sharma","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2023.159363_bb0235","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/10408363.2019.1711360","article-title":"Fructose and hepatic insulin resistance","volume":"57","author":"Softic","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.bbalip.2023.159363_bb0240","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-0030-1253421","article-title":"GLP-1 (9-36) amide metabolite suppression of glucose production in isolated mouse hepatocytes","volume":"42","author":"Tomas","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bbalip.2023.159363_bb0245","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.regpep.2011.01.003","article-title":"GLP-1-derived nonapeptide GLP-1(28-36) amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes","volume":"167","author":"Tomas","year":"2011","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bbalip.2023.159363_bb0250","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1463-1326.2010.01316.x","article-title":"Glucagon-like peptide-1(9-36) amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice","volume":"13","author":"Tomas","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbalip.2023.159363_bb0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1301\/002966402320289377","article-title":"Small amounts of dietary fructose dramatically increase hepatic glucose uptake through a novel mechanism of glucokinase activation","volume":"60","author":"Watford","year":"2002","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.bbalip.2023.159363_bb0260","article-title":"Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes","volume":"241","author":"Yaribeygi","year":"2019","journal-title":"Life Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198123000872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198123000872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:16:08Z","timestamp":1761387368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198123000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1388198123000872"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2023.159363","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of preventive effects of exendin-4 and des-fluoro-sitagliptin in a murine model of fructose-induced prediabetes","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2023.159363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"159363"}}